Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Rizatriptan 10mg oral lyophilisates sugar free |
BNF code | 0407041R0AAACAC |
Virtual Therapeutic Moiety | Rizatriptan |
Date identifier became valid | 15 Jul 2020 |
Previous product identifier | 322831007 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 10 May 2004 |
Previous name | Rizatriptan 10mg oral lyophilisates |
Basis of previous name | rINN - Recommended International Non-proprietary |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✓ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Rizatriptan benzoate |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 363573000 |
Strength value numerator | 10.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | lyophilisate.oral |
Dose Form | |
Formulation | Oral lyophilisate |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Maxalt Melt 10mg oral lyophilisates (Lexon (UK) Ltd) | |
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) | |
Maxalt Melt 10mg oral lyophilisates (Pilsco Ltd) | |
Maxalt Melt 10mg oral lyophilisates (Sigma Pharmaceuticals Plc) | |
Virtual Medicinal Product Packs | |
Rizatriptan 10mg oral lyophilisates sugar free 12 tablet | |
Rizatriptan 10mg oral lyophilisates sugar free 2 tablet | |
Rizatriptan 10mg oral lyophilisates sugar free 3 tablet | |
Rizatriptan 10mg oral lyophilisates sugar free 6 tablet |
dm+d data retrieved from TRUD: release NHSBSA_2.2.0_20250217000001, imported on 18th February 2025 at 03:53:40.